A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients

Shaobo Cao; Ya Hu; Yiming Zhao; Zhe Su; Zhiyan Xu; Xiang Gao; Quan Liao; Yupei Zhao

doi:10.18632/oncotarget.20416

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients

Shaobo Cao, Ya Hu, Yiming Zhao, Zhe Su, Zhiyan Xu, Xiang Gao, Quan Liao _ and Yupei Zhao

PDF | HTML | How to cite

Oncotarget. 2017; 8:101158-101164. https://doi.org/10.18632/oncotarget.20416

Metrics: PDF 1299 views | HTML 2205 views | ?

Abstract

Shaobo Cao1,*, Ya Hu1,*, Yiming Zhao1, Zhe Su1, Zhiyan Xu1, Xiang Gao1, Quan Liao1 and Yupei Zhao1

1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China

*These authors have contributed equally to this work

Correspondence to:

Quan Liao, email: [email protected]

Yupei Zhao, email: [email protected]

Keywords: primary hyperparathyroidism; normocalcemic parathormone elevation; parathyroidectomy; risk factors; recurrent hyperparathyroidism

Received: February 13, 2017 Accepted: June 16, 2017 Published: August 24, 2017

ABSTRACT

We retrospectively analyzed the relationship between normocalcemic parathormone elevation (NPE) and recurrence of primary hyperparathyroidism (pHPT) after surgery, as well as the risk factors of NPE. Out of 309 patients with pHPT that underwent parathyroidectomy. Six months after surgery, 75 patients exhibited NPE with high preoperative serum levels of alkaline phosphatase, calcium and intact parathyroid hormone (iPTH), postoperative day 1 iPTH, and large parathyroid volume. 15 exhibited NPE at 2 years after surgery with low serum vitamin D levels. Postoperative serum iPTH levels gradually normalized in most patients. Multivariate analysis showed that male patients were at greater risk for postoperative NPE (p<0.05). Only 3 of 309 patients showed recurrence during the follow-up period. NPE may not predict recurrent hyperparathyroidism or incomplete parathyroidectomy for benign parathyroid lesions. Postoperative NPE thus appears to be a response to severe hyperparathyroidism and vitamin D deficiency.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20416

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

A retrospective study of elevated post-operative parathormone in primary hyperparathyroid patients

Abstract